T. R. Klaenhammer Distinguished Professor at North Carolina State University

Antonio serves as the firm's Regional Advisor in Asia.

Glenda's broad strong organization skills help keep Pappas Capital running smoothly.

Drew's medical and business backgrounds bring a unique perspective to evaluating investment opportunities.

Patrick is a seasoned global executive with a proven track record of entrepreneurship, building winning cultures and growing companies small and large.

Lisa brings a depth of experience in finance and operations from her years in the Alternative Investments industry.

John W. Strohbehn Distinguished Professor of Biomedical Engineering at Duke University, Director of the Duke Center for Biomolecular and Tissue Engineering, and Director of the Duke Center for Advanced Genomic Technologies

Miranda has extensive experience working with early-stage companies in the US and Asia.

Phill brings extensive early-stage investing experience across the technology and life sciences sectors.

Mike’s extensive company management background enables him to bring an operational viewpoint to new deal opportunities and existing portfolio companies.

Dr. Humer brings a wealth of leadership experience from the pharmaceutical and life science industries.

With long-standing interests in both basic and applied cancer research, Russel has held leadership positions in national academic organizations in internal medicine.

Elizabeth has more than a decade of experience working with early-stage life science and technology companies.

Stanley has over 40 years of business and healthcare experience in China and internationally.

Karen has a long history of developing early stage technologies and launching them into the marketplace.

Tom has more than 30 years of executive management experience in the life sciences and medical device industry.

Vicky's steady support helps our team get the details right.

Glaxo Welcome Professor of Molecular Cancer Biology at the Duke University School of Medicine and Associate Director of Translational Research at the Duke Cancer Institute

Barry has been a member of the Duke University faculty for 29 years. His broad base of expertise enables him to provide a distinctive view on portfolio companies.

Art has over 40 years of operating experience as a pharmaceutical and biotechnology industry executive and venture capital investor in life science companies.

Chief of the Division of Cardiology and Director of the Duke Heart Center; 2023 American Heart Association Physician of the year

William has extensive life science investment and operating experience across the US, Europe and Asia.

Dave has an extensive career, holding senior level positions at companies such as Glaxo Inc., Glaxo Wellcome Inc., Warner Lambert Corporation and Boehringer Ingelheim Ltd.

Victor has deep operating and investing experience with early-stage companies in Asia.

Richard brings a wealth of experience and insight to Pappas Capital gained from his long career as a senior executive in the CRO industry.

J. W. and D. W. Beard Distinguished Professor of Experimental Surgery, Associate Professor Duke University

Thyagi has an in-depth knowledge of Asia and Asian markets, and a unique east-west perspective from working in both developed and emerging markets.

Bob has an extensive background in the medical device industry, including the successful sale of TYRX to Medtronic in 2013.

Tina brings a global perspective to Pappas Capital from years of working in Europe, Latin and North America, and especially Asia.

Ford is a lawyer with an extensive background in finance and accounting, and currently serves as a Senior Advisor to Pappas Capital.

Catherine has a decade of experience working with research institutes and early-stage startups in the deeptech area

June 12, 1938 - October 20, 2024

December 31, 1949 - February 4, 2025